Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
最近の投稿
- 1
Hubble Space Telescope spies dusty debris from two cosmic collisions - 210 Picturesque Campgrounds That Will Raise Your Outside Involvement with American
- 3Sea level doesn’t rise at the same rate everywhere – we mapped where Antarctica’s ice melt would have the biggest impact
- 4Virtual National Science Foundation internships aren’t just a pandemic stopgap – they can open up opportunities for more STEM students
- 5Vote In favor of Your Number one Game Control center
- Shooting of MIT professor Nuno Loureiro has police searching for a suspect
- Improving as a Pioneer: Examples from My Vocation
- the 6 Shrewd Beds for seniors: A Complete Survey
- Your big brain makes you human – count your neurons when you count your blessings
- Eating Brie, Gouda, cheddar may lower dementia risk, new study says
- Releasing Learning Experiences: A Survey of the \Learning Made Fun\ Instructive Application
- FOX8 Meteorologist Charles Ewing makes his 2025-26 winter weather predictions!
- Top Smoothie Flavor: What's Your Mix?
- Opening Potential: Self-awareness and Long lasting Learning
